Assessing the underreporting of deaths among people living with HIV in Rio de Janeiro, Brazil, from 2014 to 2019

We assessed the proportions and causes of the underreporting of deaths among people living with HIV (PLHIV) in Rio de Janeiro, Brazil, from 2014 to 2019. Demographic variables, mention of tuberculosis (TB), and CD4 cell counts closest to death were used to compare those who had HIV/AIDS mentioned on their death certificate (HMDC) to those who did not. Out of 10,698 deaths, 2,863 (26.8%) had no HMDC, from which 412 (14.4%) had external underlying cause. After excluding deaths from external causes, we found that 24% still had no HMDC. Age ≥ 40 years (OR = 1.75; 95%CI: 1.52-2.01), non-white race/ethnicity (OR = 1.16; 95%CI: 1.02-1.31), the male gender (OR = 1.25; 95%CI: 1.11-1.42), higher CD4 cell counts closest to death (OR = 1.14; 95%CI: 1.12-1.16), absence of TB (OR = 4.86; 95%CI: 3.76-6.29) and not dying within a hospital (OR = 2.61; 95%CI: 2.31-2.95) were associated with increased probabilities of not having HMDC. The proportion of deaths with no HMDC increased from 18.7% to 35.1% between 2014 and 2019. The high proportion of underreported deaths in Rio de Janeiro indicates that HIV/AIDS mortality coefficients in the state may be underestimated. With the changing patterns of mortality of PLHIV, physicians are advised to consider the broader clinical spectrum of HIV infection, and surveillance officers should improve death monitoring.

Prevention of HIV infection and new technologies

Este artigo discorre sobre a pandemia do HIV, ressaltando aspectos históricos relevantes desde sua identificação, implicações na vida cotidiana e sua repercussão em áreas do conhecimento científico e comportamentais, numa perspectiva de contextualizar o arsenal que se encontra em desenvolvimento no campo da prevenção. Descreve sumariamente estratégias de prevenção e tendências da epidemia de acordo com sua operacionalização, a partir de estudos e modelos matemáticos recentemente propostos; de modo sucinto oferece analise das pesquisas clinicas em andamento segundo níveis e estágios de desenvolvimento – as de resultados já disponíveis, resultados num futuro próximo e em longo prazo. Aponta também sucessos e fracassos das diversas estratégias investigadas nesse campo e focaliza a carência de recursos financeiros em nível global, insuficientes não apenas para fazer frente às necessidades de pesquisa como também para implementação de estratégias já existentes e de comprovada eficácia.

The UM integrated plan for support of the response to Aids in Amazonas and Bahia, Brazil

Este artigo apresenta o Plano Integrado das Nações Unidas em Apoio à resposta à AIDS no Amazonas e na Bahia, uma iniciativa de mobilização conjunta do Sistema das Nações Unidas no Brasil em implementação desde o final de 2007. Estabelecido a partir da prioridade nacional de se responder às inequidades regionais, o “Amazonaids” e o “Laços Sociaids” buscam fortalecer sinergias locais por meio de um apoio coordenado das Agências do Sistema ONU à resposta à epidemia nos dois estados. O artigo apresenta o contexto de elaboração do Plano Integrado, sua construção, regiões e temas prioritários no Amazonas e na Bahia. Descreve, ainda, a forma de organização para implementação das atividades e as lições aprendidas até o momento. O artigo conclui destacando o processo de apropriação e liderança locais na implementação das atividades e também no processo de fortalecimento de ações conjuntas e integradas das Nações Unidas no Brasil, como preconizado no processo de reforma da ONU.

DBCollHIV: a database system for collaborative HIV analysis in Brazil

We developed a database system for collaborative HIV analysis (DBCollHIV) in Brazil. The main purpose of our DBCollHIV project was to develop an HIV-integrated database system with analytical bioinformatics tools that would support the needs of Brazilian research groups for data storage and sequence analysis. Whenever authorized by the principal investigator, this system also allows the integration of data from different studies and/or the release of the data to the general public. The development of a database that combines sequences associated with clinical/epidemiological data is difficult without the active support of interdisciplinary investigators. A functional database that securely stores data and helps the investigator to manipulate their sequences before publication would be an attractive tool for investigators depositing their data and collaborating with other groups. DBCollHIV allows investigators to manipulate their own datasets, as well as integrating molecular and clinical HIV data, in an innovative fashion.

Dramatic improvement in survival among adult Brazilian AIDS patients

BACKGROUND

Since the last study of survival time among Brazilian AIDS patients, care has improved steadily, culminating in a controversial policy of universal free access to triple antiretroviral treatment since 1996. This large, national study examined how these changes have impacted survival.

METHODS

Using national data for cases diagnosed in 1995 and 1996, we randomly selected 3930 adult AIDS cases from 18 cities in seven states representing all regions of Brazil. Trained abstracters reviewed medical records, determining dates of diagnosis and death or last contact, exposure category, treatment, and demographics. After review, 2821 cases met the inclusion criteria and were available for Kaplan-Meier and proportional hazards analysis. Data from the earlier study were re-analyzed for comparison.

RESULTS

Median survival was 5 months for cases diagnosed in the 1980s, 18 months for those diagnosed in 1995, and 58 months for those diagnosed in 1996. Predictors of longer survival in univariate analysis included antiretroviral treatment, year of diagnosis, higher education, sexual exposure category, female sex, and Pneumocystis carinii pneumonia prophylaxis. In multivariate analysis, the predictive value of most of these was attenuated or disappeared, leaving antiretroviral treatment as the main predictor of survival.

CONCLUSIONS

Survival time has increased substantially for adult Brazilian AIDS patients. The timing of these gains and analysis of the predictors of survival both indicate antiretroviral treatment as the cause. These findings demonstrate that universal access to antiretroviral treatment in a developing country can produce benefits on the same scale as in richer countries.

Access to antiretroviral treatment in Latin American countries and the Caribbean

OBJECTIVES

To assess the access to antiretroviral therapy in the Latin America and Caribbean region and the main issues involved.

METHODS

A review of National AIDS Programmes reports, published studies on HIV access to antiretroviral drugs, and personal communications from National AIDS Programmes in the region.

RESULTS

Most countries have, or are in the process of developing, laws and regulations to ensure better access to antiretroviral drugs for people in need. However, there are still many countries that either have not implemented policies or do not have policies. There has been an important decrease in the cost of drugs, but prices are still too high for all countries to afford them. The benefits in decreased mortality and hospitalizations in the countries with high coverage are significant. The number of people receiving antiretroviral therapy has been estimated to be close to 170,000 individuals; however, this figure only represents a fraction of the people in need in the region. Some different strategies will have to be implemented in order to increase coverage.

CONCLUSION

Renewed efforts are needed from both governments and international community organizations to strengthen the health services and increase access to antiretroviral drugs.

[Risk behavior among Brazilian Military conscripts, 1998: an study of HIV infections following socioeconomic differences]

A study of HIV-related risk behavior was carried out in 1998 among Brazilian military conscripts aged 17-20 years. A sample of 30,318 subjects was selected in three strata, pertaining to counties from: 1) the North and Central-West (N/CW); 2) South (S); and the states of Rio de Janeiro and São Paulo. HIV prevalence rates were estimated in all strata. The objective of this paper was to analyze the results according to differences in socioeconomic status (SES). The statistical analysis used an index of sexual risk behavior and logistic regression models. The N/CW stratum showed the worst indicators for SES, sexual risk behavior, and sexually transmitted infections (STIs), as well as the highest HIV seroprevalence rate. The best indicators for all variables were found in the RJ/SP stratum. The South showed intermediate results. Level of schooling also played a relevant role. In all three strata the conscripts with an incomplete high school education displayed the worst sexual risk behavior index, shown to be a relevant predictor of STI-related problems, including HIV infection.

Comportamento de risco dos conscritos do Exército Brasileiro, 1998: uma apreciação da infecção pelo HIV segundo diferenciais sócio-econômicos

Uma pesquisa de comportamento de risco ao HIV foi conduzida entre conscritos (17-20 anos) do Exército em 1998. A amostra (30.318) foi selecionada em três estratos: 1) municípios das regiões Norte e Centro-Oeste (N/CO); 2) municípios da região Sul (S); 3) municípios dos estados do Rio de Janeiro e São Paulo (RJ/SP), estimando-se a prevalência de infecção pelo HIV em cada estrato. O objetivo deste trabalho foi o de apreciar os resultados por nível sócio-econômico (NSE). A análise estatística utilizou um índice de comportamento sexual de risco para HIV e modelos de regressão logística. O estrato N/CO apresentou os piores indicadores - os relativos ao NSE, ao comportamento sexual de risco ou aos problemas relacionados às infecções sexualmente transmissíveis (IST) - assim como a maior proporção de infectados por HIV. Os melhores indicadores foram encontrados no estrato RJ/SP. O Sul mostrou resultados intermediários. O grau de escolaridade teve papel relevante. Os conscritos com primeiro grau incompleto apresentaram o pior índice de comportamento sexual de risco, o qual se mostrou importante preditor dos problemas relacionados às IST, incluindo a infecção por HIV.

[Acquired immunodeficiency syndrome in Brazil and the State of Ceará]

Since February 1998, a total of 129,000 cases of acquired immune deficiency syndrome have been reported in Brazil. The cumulative frequency of the disease is 82 per 100,000 which makes Brazil one of the countries moderately affected. There are considerable differences between regions in the frequency of cases, from 25 per 100,000 in the north and north east to 152 per 100,000 in the south east. Sexual intercourse is still the predominant means of transmission. Transmission in the early years of the epidemic was mostly between homosexuals and bisexuals, but transmission via heterosexual intercourse is increasing. The contribution made by intravenous drug use differs between the regions, and is particularly large in the mid-south region. A pilot project in the city of Fortaleza has shown that it is possible to successfully integrate the diagnosis of STD and AIDS in health care units at an intermediate level. This appears to be an appropriate strategy for the integration of STD treatment into primary health care in Ceará State. The non-uniform pattern of development of this epidemic must be taken into account in epidemiological analyses of AIDS in Brazil.

HIV specific humoral immune response in Rio de Janeiro, Brazil. The HEC/Fiocruz AIDS Clinical Research Group

Efforts to characterize HIV-1 polymorphism and anti-HIV immune response are being made in areas where anti-HIV/AIDS vaccines are to be employed. Anti-HIV-1 humoral immune response is being studied in infected individuals residents in Rio de Janeiro, in distinct cohorts involving recent seroconvertors, pregnant women or intravenous drug users (IDU). Comparative analyses of specificity of antibody response towards epitopes important for anti-HIV-1 immune response indicate quantitative differences between cohorts, with an exceptionally strong response in IDUs and weakest response in pregnant women. However, a comparative analysis between pregnant women cohorts from Rio de Janeiro and Rio Grande do Sul indicated an even lower response (with exception of the anti-V3-C clade peptide recognition) for the southern cohort. Studies analysing the immune function of the humoral response indicate a quite elevated occurrence of antibodies capable for neutralizing heterologous primary HIV-1 isolates from Rio de Janeiro. Attempts to correlate seroreactivity with HIV-1 neutralization with respect to HIV-1 polymorphism were not very successful: while the Brazilian B clade B " variant could be recognized by binding assays, no significant distinction of HIV-1 clades/variants was observed in viral neutralization assays.

AIDS and condoms in Brasilia: a telephone survey

A telephone survey was conducted to measure AIDS knowledge, media usage and condom attitudes and behaviors among 500 adults aged 18 to 49 in Brasilia, as well as to evaluate the feasibility of the telephone survey method in a developing country. The response rate was 91.6%. Respondents had good knowledge about correct modes of HIV transmission and prevention but also believed HIV was transmitted through blood donation, public toilets, swimming pools, and mosquito bites. TV and newspapers were the most important sources of information on health matters and AIDS, though health workers were considered the most credible sources of such information. Only 19% of sexual encounters in the 4 weeks prior to the survey included condoms. Single and younger respondents and those with more positive attitudes used condoms more frequently. More work is needed to identify appropriate messages to motivate people to use condoms. Telephone surveys regarding AIDS and sexual attitudes and behaviors are feasible in Brasilia, a planned community with universal telephone coverage.

Determinants of survival in adult Brazilian AIDS patients, 1982-1989. The Brazilian State AIDS Program Co-Ordinators

OBJECTIVE

Little has been published about the length and determinants of survival for persons with AIDS in developing countries. This study examined the survival experience of Brazilian AIDS patients from 1982 to 1989.

DESIGN

A retrospective cohort study involving record review of reported AIDS cases.

METHODS

We obtained information about 2135 adult AIDS patients in Brazil. Local health officials supplied data regarding demographic and clinical characteristics and length of survival. Statistical techniques of survival analysis were applied.

RESULTS

Median survival was 5.1 months, much shorter than in developed countries, and there was no improvement in survival for cases diagnosed more recently. Younger patients and those in the intravenous drug use exposure category lived longer than other AIDS patients. Those presenting with Kaposi's sarcoma, esophageal candidiasis, and tuberculosis fared relatively well, while those presenting with multiple diagnoses or toxoplasmosis did more poorly.

CONCLUSIONS

These results tend to confirm the predictors of AIDS survival previously reported from developed countries and to document the poor survival of AIDS patients in the developing world.